CeGaT News

Tumor Mutational Burden and Other Biomarkers Help to Assess the Efficacy of Immunotherapies

Immunotherapy has revolutionized the treatment of many types of cancer by taking advantage of the immune system’s ability to fight cancer cells. In the last few years, a growing number of immunotherapy-based clinical trials were launched to increase success rates further. Specific biomarkers help to stratify patients for the best treatment choice, and also to […]

CeGaT logo

CeGaT Remains Up and Running During COVID-19 – Offering Genetic Diagnostics and Research and Pharma Solution Services

CeGaT has taken all necessary precautions to protect the health of customers and team members and to safeguard uninterrupted business operations. All samples are processed as usual. We take the situation seriously and monitor the current developments so that we can react quickly to new circumstances and take appropriate action. Our aim is to ensure […]

Saving a Little Girl‘s Life

An exact diagnosis is the basis for an optimal treatment. Here is a case from our daily work where exome diagnostics saved a little girl’s life.  Our patient had shown signs of severe illness at an early age. Her parents sought medical assistance when she was about six months old. Examining the baby, the physicians identified a bone marrow developmental defect. […]

Four doctors in the discussion about the results.

CeGaT Brings New Dimension to Exome Diagnostics

CeGaT aims to solve all genetically-caused cases of disease to help physicians state a diagnosis. To pursue this goal, CeGaT incorporated its long-term expertise and latest scientific knowledge in an innovative diagnostic tool: CeGaT Exome Xtra is the most powerful genetic diagnostic option for patients with complex, unspecific, and rare diseases. CeGaT has been utilizing […]

Male and female scientists standing in the labarotary with crossec hands and in the background two emploees are working there.

CeGaT Broadens Service Portfolio for Research and Pharmaceutical Industry

CeGaT GmbH expands its business division for sequencing services: Through “Research and Pharma Solutions”, the globally operating company offers individual approaches for projects from science and the pharmaceutical industry. The Tübingen-based company, which was founded primarily as a genetic diagnostics provider, is constantly expanding its expertise and portfolio in the field of custom sequencing. It […]